Ken Griffin Nova Bay Pharmaceuticals, Inc. Transaction History

Citadel Advisors LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$0.58 - $0.69 $20,211 - $24,045	-34,848 Reduced 37.91%	57,069 $37,000
Q2 2021 Aug 16, 2021	BUY	$0.61 - $0.97 $11,503 - $18,293	18,859 Added 25.81%	91,917 $61,000
Q1 2021 May 17, 2021	SELL	$0.73 - $1.43 $6,015 - $11,783	-8,240 Reduced 10.14%	73,058 $66,000
Q4 2020 Feb 16, 2021	BUY	$0.52 - $0.81 $30,901 - $48,135	59,426 Added 271.7%	81,298 $57,000
Q3 2020 Nov 16, 2020	SELL	$0.72 - $1.61 $13,870 - $31,015	-19,264 Reduced 46.83%	21,872 $16,000
Q2 2020 Aug 14, 2020	BUY	$0.71 - $1.29 $29,206 - $53,065	41,136 New	41,136 $47,000
Q2 2019 Aug 14, 2019	SELL	$0.28 - $3.1 $3,465 - $38,371	-12,378 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$0.91 - $1.97 $11,263 - $24,384	12,378 New	12,378 $0

2.94K

Ticker NBY
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,988,400
Market Cap $46.8M
Description
NovaBay Pharmaceuticals, Inc., a pharmaceutical company, develops and sells eyecare and skincare products in the United States and internationally. It offers Avenova, a solution for removing foreign materials, including microorganisms and debris from skin around the eye, such as the eyelid; and wound care products under the NeutroPhase and Phase...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.